The clinical utility of tissue polymerase chain reaction, tissue culture and tissue histology in blood culture-negative infective endocarditis in South Africa – insights from the Groote Schuur Hospital Infective Endocarditis Registry
DOI:
https://doi.org/10.7196/SAMJ.2025.v115i1.2529Keywords:
Culture Negative Infective Endocarditis, Blood culture, polymerase chain recation, serology, EndocarditisAbstract
Background. Infective endocarditis (IE) poses significant diagnostic and therapeutic challenges, especially in cases of blood culture-negative infective endocarditis (BCNIE). Among patients undergoing surgery for IE, valve tissue may be evaluated for additional microbiological information by performing a broad-range 16S rDNA polymerase chain reaction (PCR) test, tissue culture and tissue histopathology. In patients with BCNIE, these diagnostic tests may identify the causative agents, guide further clinical management and improve local IE-related epidemiological data. The clinical utility of additional analysis of explanted tissue in a local South African (SA) setting has yet to be described.
Objectives. To assess the clinical utility of performing PCR, culture and histopathology on the tissue of surgically explanted valves in BCNIE patients in an SA public sector hospital. We assess their diagnostic yield and treatment impact in a cohort of BCNIE patients treated with empirical antibiotic regimens.
Methods. We analysed data from the Groote Schuur Hospital (GSH) Infective Endocarditis Registry, a prospective observational study of adult patients with infective endocarditis. Participants for this analysis were selected based on clinical and pathological criteria for IE and negative blood cultures. All participants were treated between January 2017 and March 2021.
Results. During the study period, we identified 165 IE cases, 57 (34.5%) of which were blood-culture negative. BCNIE patients had a mean (standard deviation) age of 40.2 (13.4) years, and 41 (71.9%) were male. Twenty-seven of the 57 BCNIE patients underwent cardiac surgery and had tissue analysis performed. Tissue PCR identified an aetiological agent in 17/27 (63%) cases, with Bartonella spp. (12/27, 44%) being the most common organism. Tissue culture was positive in 3/27 (11%) cases, but the organisms identified were thought to reflect sample contamination. Tissue histopathology was performed in 22/27 (81.5%) cases and provided macroscopic confirmation of IE, but did not identify any specific organisms in any of the specimens. Only a small subset of the overall BCNIE cohort (11/57 (19.3%)) had serum serology for Bartonella spp. and Coxiella spp. performed, and 5/11 (45.5%) were positive for Bartonella spp. There was a 100% concordance rate between positive serum serology and tissue PCR. Tissue PCR impacted the antimicrobial regimen in 20/27 (74%) cases. Tissue culture and tissue histopathology did not influence antibiotic regimens in any patients.
Conclusion. In this single-centre study, perioperative serum serological testing was underutilised in BCNIE. Tissue PCR was valuable in determining the aetiology of BCNIE, and influenced management. Tissue culture and histopathology had a poor yield and added little value in identifying the microbiological cause of BCNIE. Finally, the most common BCNIE causative organism identified by additional non-culture testing in our setting is Bartonella spp.
References
1. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36(44):3075-3128. https://doi. org/10.1093/eurheartj/ehv319
2. Lee A, Mirrett S, Reller LB, Weinstein MP. Detection of bloodstream infections in adults: How many blood cultures are needed? J Clin Microbiol 2007;45(11):3546-3548. https://doi.org/10.1128/ JCM.01555-07
3. Ebato M. Blood culture-negative endocarditis. InTech; 2018. https://doi.org/10.5772/intechopen.76767 4. Raoult D, Casalta JP, Richet H, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 2005;43(10):5238-5242. https://doi.org/10.1128/
JCM.43.10.5238-5242.2005
5. Benslimani A, Fenollar F, Lepidi H, Raoult D. Bacterial zoonoses and infective endocarditis, Algeria. Emerg Infect Dis 2005;11(2):216-224. https://doi.org/10.3201/eid1102.040668
6. De Villiers MC, Viljoen CA, Manning K, et al. The changing landscape of infective endocarditis in South Africa. S Afr Med J 2019;109(8):592-596. https://doi.org/10.7196/SAMJ.2019.v109i8.13888
7. Koegelenberg CF, Doubell AF, Orth H, Reuter H. Infective endocarditis in the Western Cape Province
of South Africa: A three-year prospective study. QJM 2003;96(3):217-225. https://doi.org/10.1093/
qjmed/hcg028.
8. Mkoko P, Cupido BJ, Hitzeroth J, Chin A, Ntsekhe M. Profile, presentation and outcomes of prosthetic valve endocarditis in a South African tertiary hospital: Insights from the Groote Schuur Hospital Infective Endocarditis Registry. S Afr Med J 2022;112(4):e13554. https://doi.org/10.7196/SAMJ.2022. v112i4.16146
9. Kong WKF, Salsano A, Giacobbe DR, et al. Outcomes of culture-negative vs. culture-positive infective endocarditis: The ESC-EORP EURO-ENDO registry. Eur Heart J 2022;43(29):2770-2780. https://doi. org/10.1093/eurheartj/ehac307
10. Pecoraro AJK, Pienaar C, Herbst PG, et al. Causes of infective endocarditis in the Western Cape, South Africa: A prospective cohort study using a set protocol for organism detection and central decision making by an endocarditis team. BMJ Open 2021;11(12):e053169. https://doi.org/10.1136/ bmjopen-2021-053169.
11. Fournier PE, Gouriet F, Casalta JP, et al. Blood culture-negative endocarditis: Improving the diagnostic yield using new diagnostic tools. Medicine 2017;96(47):e8392. https://doi.org/10.1097/ MD.0000000000008392.
12. Wolf LA, Cherry NA, Maggi RG, Breitschwerdt EB. In pursuit of a stealth pathogen: Laboratory diagnosis of Bartonellosis. Clin Microbiol News 2014;36(5):33-39. https://doi.org/10.1016/j. clinmicnews.2014.02.001
13. Cahill TJ, Baddour LM, Habib G, et al. Challenges in infective endocarditis. J Am Coll Cardiol 2017;69(3):325-344. https://doi.org/10.1016/j.jacc.2016.10.066
14. Murdoch DR. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med 2009;169(5):463. https://doi.org/10.1001/archinternmed.2008.603
15. Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: A prospective study of 819 new cases. Clin Infect Dis 2010;51(2):131-140. https://doi. org/10.1086/653675
16. Houpikian P, Raoult D. Diagnostic methods. Current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Cardiol Clin 2003;21(2):207-217. https://doi. org/10.1016/s0733-8651(03)00028-6
17. Armstrong C, Kuhn TC, Dufner M, et al. The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: A cohort study of 146 surgical cases confirmed by histopathology. Clin Res Cardiol 2021;110(3):332-342. https://doi.org/10.1007/s00392-020-01678-x
18. Casalta JP, Gouriet F, Roux V, Thuny F, Habib G, Raoult D. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 2009;28(6):569-573. https://doi.org/10.1007/s10096-008-0672-6
19. Fournier PE, Lelievre H, Eykyn SJ, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: A study of 48 patients. Medicine 2001;80(4):245-251. https://doi.org/10.1097/00005792-200107000-00003
20. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004;48(6):1921-1933. https://doi.org/10.1128/AAC.48.6.1921-1933.2004
21. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation 2005;111(23):e394-e434. https://doi.org/10.1161/CIRCULATIONAHA.105.165564
22. Eiken PW, Edwards WD, Tazelaar HD, McBane RD, Zehr KJ. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985 - 2000. Mayo Clin Proc 2001;76(12):1204-1212. https:// doi.org/10.4065/76.12.1204
23. Abdool Karim SS. The South African response to the pandemic. N Engl J Med 2020;382(24):e95.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 W Endres, P Mkoko, M Ntsekhe

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.